長期休薬の後に発症したプロピルチオウラシル誘発性ANCA関連血管炎の一例

    Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery.     A 46-year-old woman with a...

Full description

Saved in:
Bibliographic Details
Published in臨床リウマチ Vol. 22; no. 2; pp. 236 - 242
Main Authors 孫, 瑛洙, 伊藤, 量基, 和田, 孝彦, 木畑, 佳代子, 嶋元, 佳子, 真鍋, 和代, 安室, 秀樹, 田中, 晶大, 澤井, 宏和, 尾崎, 吉郎, 福原, 資郎
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本臨床リウマチ学会 2010
The Japanese Society for Clinical Rheumatology and Related Research
Subjects
Online AccessGet full text
ISSN0914-8760
2189-0595
DOI10.14961/cra.22.236

Cover

Abstract     Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery.     A 46-year-old woman with a 26-year history of Basedow’s disease and 12-year history of rheumatoid arthritis was admitted with high fever and pulmonary hemorrhage. Results of laboratory evaluation were: CRP 7.54 mg/dL, Cr 4.54 mg/dL, Hb 6.8 g/dL.     A diagnosis of MPO-ANCA-associated vasculitis was strongly suggested by positivity for MPO-ANCA (352EU), pulmonary hemorrhage, acute nephritis, and scattered purpura on the limbs. However patient condition did not allow histological confirmation of the diagnosis.     She was treated with methylprednisolone pulse therapy and prednisolone. Consolidation on chest X-ray and C-reactive protein levels improved rapidly. However, pulmonary hemorrhage was repeated four times with tapering of prednisolone. The titer of MPO-ANCA showed a linear decrease during the clinical course. The recurrence of pulmonary hemorrhage was correlated with the level of CRP.     MPO-ANCA-associated vasculitis was caused by propylthiouracil. It was reported that serum ANCA may still remain positive in the majority of patients with propylthiouracil-induced MPO-ANCA positive for up to 5 years. This patient developed MPO-ANCA-associated vasculitis from taking propylthiouracil 20 years previously. ANCA was detected in more than 20% of patients treated with propylthiouracil, but only 6.5% of patients showed clinical evidence of vasculitis. Long-term follow-up may be necessary after discontinuation of propylthiouracil.    Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた.
AbstractList Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた.
    Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with propylthiouracil for Basedow’s disease. Propylthiouracil administration was ceased 20 years ago following thyroid surgery.     A 46-year-old woman with a 26-year history of Basedow’s disease and 12-year history of rheumatoid arthritis was admitted with high fever and pulmonary hemorrhage. Results of laboratory evaluation were: CRP 7.54 mg/dL, Cr 4.54 mg/dL, Hb 6.8 g/dL.     A diagnosis of MPO-ANCA-associated vasculitis was strongly suggested by positivity for MPO-ANCA (352EU), pulmonary hemorrhage, acute nephritis, and scattered purpura on the limbs. However patient condition did not allow histological confirmation of the diagnosis.     She was treated with methylprednisolone pulse therapy and prednisolone. Consolidation on chest X-ray and C-reactive protein levels improved rapidly. However, pulmonary hemorrhage was repeated four times with tapering of prednisolone. The titer of MPO-ANCA showed a linear decrease during the clinical course. The recurrence of pulmonary hemorrhage was correlated with the level of CRP.     MPO-ANCA-associated vasculitis was caused by propylthiouracil. It was reported that serum ANCA may still remain positive in the majority of patients with propylthiouracil-induced MPO-ANCA positive for up to 5 years. This patient developed MPO-ANCA-associated vasculitis from taking propylthiouracil 20 years previously. ANCA was detected in more than 20% of patients treated with propylthiouracil, but only 6.5% of patients showed clinical evidence of vasculitis. Long-term follow-up may be necessary after discontinuation of propylthiouracil.    Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気管から泡沫状血清分泌物が吸引され,MPO-ANCA 352EUなどからANCA関連血管炎に起因する肺胞出血と診断.mPSLパルス療法などで加療した.本症例は内服終了長期を経て発症したPTUに起因するANCA関連血管炎と考えられた.
Author 真鍋, 和代
安室, 秀樹
澤井, 宏和
福原, 資郎
嶋元, 佳子
尾崎, 吉郎
木畑, 佳代子
伊藤, 量基
孫, 瑛洙
和田, 孝彦
田中, 晶大
Author_FL Manabe Kazuyo
尾崎 吉郎
Ito Tomoki
木畑 佳代子
Shimamoto Keiko
Amuro Hideki
Wada Takahiko
田中 晶大
孫 瑛洙
Sawai Hirokazu
Fukuhara Shirou
Author_FL_xml – sequence: 1
  fullname: 尾崎 吉郎
– sequence: 2
  fullname: Manabe Kazuyo
– sequence: 3
  fullname: 木畑 佳代子
– sequence: 4
  fullname: 田中 晶大
– sequence: 5
  fullname: Shimamoto Keiko
– sequence: 6
  fullname: Amuro Hideki
– sequence: 7
  fullname: 孫 瑛洙
– sequence: 8
  fullname: Sawai Hirokazu
– sequence: 9
  fullname: Ito Tomoki
– sequence: 10
  fullname: Wada Takahiko
– sequence: 11
  fullname: Fukuhara Shirou
Author_xml – sequence: 1
  fullname: 孫, 瑛洙
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 伊藤, 量基
  organization: 関西医科大学内科学第一講座
– sequence: 1
  fullname: 和田, 孝彦
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 木畑, 佳代子
  organization: 関西医科大学内科学第一講座
– sequence: 1
  fullname: 嶋元, 佳子
  organization: 関西医科大学内科学第一講座
– sequence: 1
  fullname: 真鍋, 和代
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 安室, 秀樹
  organization: 関西医科大学内科学第一講座
– sequence: 1
  fullname: 田中, 晶大
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 澤井, 宏和
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 尾崎, 吉郎
  organization: 関西医科大学附属枚方病院リウマチ・膠原病科
– sequence: 1
  fullname: 福原, 資郎
  organization: 関西医科大学内科学第一講座
BackLink https://cir.nii.ac.jp/crid/1390001204341192448$$DView record in CiNii
BookMark eNpFkEtLAlEAhS9hkJmr_kLbsfua8d5FC5FeILWp9TAz906NmMXopt08Fi2KICgtCMSCIi23RoR_5pqPf9GUQZtz4PBx4JxFkKoeVyUAywjmEOUGWnV8K4dxDhNjDqQxYlyDOtdTIA05ohrLG3ABZGs1z4aQQog4w2kgpjf90X1r-Hk1abyqsPc1uFBhd3z3MW6eqbCpwpaKmyp-U_G1irsqDlXUUdGTil9U1E-SSec2gUfBc2GnWJg2HqbB46QdjHvtcXSZ1A3fg-HgfAnMu1alJrN_ngH7G-t7xS2ttLu5XSyUtDImkGk6g7bDpUGx0CHNS064FEjozEZ5JqFjuYLanLmQ2szVqURCukJCHRFbCIkRyYCVWW_V80zH-1FEOEy2YkgJRYhjSlmCrc2wcq1uHUjzxPeOLP_UtPy651SkmfxoYmziXyHGf35o-WbZIt_74Y4C
ContentType Journal Article
Copyright 2010 一般社団法人日本臨床リウマチ学会
Copyright_xml – notice: 2010 一般社団法人日本臨床リウマチ学会
DBID RYH
DOI 10.14961/cra.22.236
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Anti-neutrophil cytoplasmic antibody-associated vasculitis after long-term interruption of propylthiouracil therapy
DocumentTitle_FL Anti-neutrophil cytoplasmic antibody-associated vasculitis after long-term interruption of propylthiouracil therapy
EISSN 2189-0595
EndPage 242
ExternalDocumentID 130005127455
article_cra_22_2_22_236_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j2308-580bc9e642d5047e939ed1d58b178e0cafd4b98f04b8f54e1defde0513bdde213
ISSN 0914-8760
IngestDate Thu Jun 26 23:42:58 EDT 2025
Wed Sep 03 06:01:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2308-580bc9e642d5047e939ed1d58b178e0cafd4b98f04b8f54e1defde0513bdde213
OpenAccessLink https://www.jstage.jst.go.jp/article/cra/22/2/22_236/_article/-char/ja
PageCount 7
ParticipantIDs nii_cinii_1390001204341192448
jstage_primary_article_cra_22_2_22_236_article_char_ja
PublicationCentury 2000
PublicationDate 2010
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – year: 2010
  text: 2010
PublicationDecade 2010
PublicationTitle 臨床リウマチ
PublicationTitleAlternate 臨床リウマチ
PublicationTitle_FL Clinical Rheumatology and Related Research
臨床リウマチ
PublicationYear 2010
Publisher 一般社団法人 日本臨床リウマチ学会
The Japanese Society for Clinical Rheumatology and Related Research
Publisher_xml – name: 一般社団法人 日本臨床リウマチ学会
– name: The Japanese Society for Clinical Rheumatology and Related Research
References 7) Gao, Y., Zhao, M.H.: Drug-induced antineutrophil cytoplasmic antibodyassociated vasculitis. Nephrol., 14: 33-41, 2009.
4) Dolman, K.M., Gans, R.O., Vervaat, T.J., et al.: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylyhiouracil therapy. Lancet, 342: 651-652, 1993.
5) Fujieda, M., Hattori, M., Kurayama, H., et al.: Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol., 13: 437-445, 2002.
13) Ohtsuka, M., Yamashita, Y., Doi, M., et al.: Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J., 10: 1405-1407, 1997.
16) Stankus, S.J., Johnson, N.T.: Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest, 102: 1595-1596, 1992.
2) Brimness, J., Halberg, P., Jacobsen, S., et al.: Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin. Exp. Immunol., 110: 250-256, 1997.
14) Sato, H., Hattori, M., Fujieda, M., et al.: High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J. Clin. Endocrinol. Metab., 85: 4270-4273, 2000.
17) Vittecoq, O., Jouen-Beades, F., Kezanowska, K., et al.: Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford), 39:481-489, 2000.
1) Amrhein, J.A., Kenny, M., Ross, D.: Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J. Pediatr., 76: 54-63, 1970.
12) Noh, J.Y., Yasuda, S., Sato, S., et al.: Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab., 94: 2806-2811, 2009.
10) Merkel, P.A.: Drug-induced vasculitis. Rheum. Dis. Clin. North. Am., 27: 849-862, 2001.
3) Chen, Y.X., Yu, H.J., Ni, L.Y., et al.: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J. Rheumatol., 34: 2451-2456, 2007.
11) Noh, J.Y., Asari, T., Hamada, N., et al.: Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves’ disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestation. Clin. Endocrinol. (Oxf.), 54: 651-654, 2001.
8) Geffriaud-Ricouard, C., Noël, L.H., Chauveau, D., et al.: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol., 39: 125-136, 1993.
6) Gao, Y., Chen, M., Ye, H., et al.: Longterm outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford), 47: 1515-1520, 2008.
9) Goto, A., Mukai, M., Notoya, A., et al.: Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report, 15: 118-122, 2005.
15) Sera, N., Ashizawa, K., Ando, T., et al.: Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid, 10: 595-599, 2000.
References_xml – reference: 2) Brimness, J., Halberg, P., Jacobsen, S., et al.: Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin. Exp. Immunol., 110: 250-256, 1997.
– reference: 5) Fujieda, M., Hattori, M., Kurayama, H., et al.: Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol., 13: 437-445, 2002.
– reference: 14) Sato, H., Hattori, M., Fujieda, M., et al.: High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves’ disease treated with propylthiouracil. J. Clin. Endocrinol. Metab., 85: 4270-4273, 2000.
– reference: 15) Sera, N., Ashizawa, K., Ando, T., et al.: Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves’ disease. Thyroid, 10: 595-599, 2000.
– reference: 16) Stankus, S.J., Johnson, N.T.: Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest, 102: 1595-1596, 1992.
– reference: 8) Geffriaud-Ricouard, C., Noël, L.H., Chauveau, D., et al.: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol., 39: 125-136, 1993.
– reference: 6) Gao, Y., Chen, M., Ye, H., et al.: Longterm outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford), 47: 1515-1520, 2008.
– reference: 17) Vittecoq, O., Jouen-Beades, F., Kezanowska, K., et al.: Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford), 39:481-489, 2000.
– reference: 10) Merkel, P.A.: Drug-induced vasculitis. Rheum. Dis. Clin. North. Am., 27: 849-862, 2001.
– reference: 12) Noh, J.Y., Yasuda, S., Sato, S., et al.: Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab., 94: 2806-2811, 2009.
– reference: 7) Gao, Y., Zhao, M.H.: Drug-induced antineutrophil cytoplasmic antibodyassociated vasculitis. Nephrol., 14: 33-41, 2009.
– reference: 9) Goto, A., Mukai, M., Notoya, A., et al.: Rheumatoid arthritis complicated with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: a case report, 15: 118-122, 2005.
– reference: 1) Amrhein, J.A., Kenny, M., Ross, D.: Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J. Pediatr., 76: 54-63, 1970.
– reference: 4) Dolman, K.M., Gans, R.O., Vervaat, T.J., et al.: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylyhiouracil therapy. Lancet, 342: 651-652, 1993.
– reference: 11) Noh, J.Y., Asari, T., Hamada, N., et al.: Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves’ disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestation. Clin. Endocrinol. (Oxf.), 54: 651-654, 2001.
– reference: 3) Chen, Y.X., Yu, H.J., Ni, L.Y., et al.: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J. Rheumatol., 34: 2451-2456, 2007.
– reference: 13) Ohtsuka, M., Yamashita, Y., Doi, M., et al.: Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J., 10: 1405-1407, 1997.
SSID ssib004001982
ssj0003304618
ssib029852172
ssib058494229
Score 1.8118515
Snippet Basedow氏病に対して甲状腺亜全摘を受けるまでの間プロピルチオウラシル(PTU)内服治療を受け,20年前に内服終了となった46歳の女性が,喀血を主訴に紹介された.気...
    Here, we report a case of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPOANCA)-related vasculitis. The patient had been treated with...
SourceID nii
jstage
SourceType Publisher
StartPage 236
SubjectTerms adverse effects
antineutrophil cytoplasmic antibodies
propylthiouracil
rheumatoid arthritis
Title 長期休薬の後に発症したプロピルチオウラシル誘発性ANCA関連血管炎の一例
URI https://www.jstage.jst.go.jp/article/cra/22/2/22_236/_article/-char/ja
https://cir.nii.ac.jp/crid/1390001204341192448
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床リウマチ, 2010/06/30, Vol.22(2), pp.236-242
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2189-0595
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0003304618
  issn: 0914-8760
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-1XryIomLVSg_OSbYmk8lk5jjZZimCBaGF4iXkE7uHKqW9eNqPgwdFELRVEEoVFFvttSLSfya12_4XvjdJdiP1UAvL8Pbtb968j0nmzexkYhh3MshyKY-thhO7ZoOFWdgQ3I4bWcKdiEkeJfrvggdzfHaB3V90FsfGH9V2La2tRtPxs38-V3KWqAIP4opPyf5HZIdCgQE0xBdKiDCUp4ox8SWRDvFc4nMim0S2iM-IB4RFfEEkJ6pJfBuyRaJ84gPSJ2LI8YjvEimJpzThEuGWP8kh0dKEXXFsomYqDqs4XkkAHglKlKoIXmFkyfHcWi2BSClqanDceKFcNddU2jYwgCKBXFtXsJCGCmAP0ECAUOHXjAT7hcYwba1Xz75RAhiphPaFIkJV2pzQWPpDq6o-iZXAfNAcuqVWGhzkodIeI1KOYDoEKFug3xQr8BKbFi2UAm4drY9oBtVxcdGrnlngdWNyRqsKrfIRXsdaFX5zUAuNZwjzbE142l2FBLO-sFNu7sWLsOYqKIXuKlpbT3cVWcjgKBJaQbCCz13dPOCcSo_m2bxaeZNXXVbVV40thgNooWyqeZAkygZk6U59UKW0dvOg9RHS5rVkixZHq50Yx-EugQN5vBJOUzo9rPPXwejlZRcAKKA0oLqweTDkPw5XgjbMnc5TXKvDDRsPRX3ssuToXCcqhYPvaqu-Q14uGS2nDpjV2frVBDqxq3xQPu6Lut4baQqpbBsmdnhix7nlpaVatjp_ybhYTjOnVKHkZWOsHV4xkuO3e4cfNg9-vT5a_5Z3d3_vv8y7O4P3Pwcbz_PuRt7dzPsbef973n-T93fyfjfvbee9z3n_a97bA87R9jsAH3a-4PV5vP7xuPPpaKsz2N0a9F6BuIMfnYP9F1eNhZY_35xtlG9ZabSpbeJjl2YUy5Qzmjgmc1NpyzSxEkdElitSMw6zhEVSZCaLROaw1ErSLElhLLcjSI2oZV8zxpefLKfXjanEzASFO73JwoTRKBZmaJkpT5ljc2nKdMLghWuCp8VROsEpYzhhTIIrg3gJS5iz6vVzk0EGjutHTNw4q-CbxoViOxCuqd4yxldX1tJJmGWsRrd1d_kDnvbt4g
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%95%B7%E6%9C%9F%E4%BC%91%E8%96%AC%E3%81%AE%E5%BE%8C%E3%81%AB%E7%99%BA%E7%97%87%E3%81%97%E3%81%9F%E3%83%97%E3%83%AD%E3%83%94%E3%83%AB%E3%83%81%E3%82%AA%E3%82%A6%E3%83%A9%E3%82%B7%E3%83%AB%E8%AA%98%E7%99%BA%E6%80%A7ANCA%E9%96%A2%E9%80%A3%E8%A1%80%E7%AE%A1%E7%82%8E%E3%81%AE%E4%B8%80%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81&rft.au=%E5%AD%AB%2C+%E7%91%9B%E6%B4%99&rft.au=%E4%BC%8A%E8%97%A4%2C+%E9%87%8F%E5%9F%BA&rft.au=%E5%92%8C%E7%94%B0%2C+%E5%AD%9D%E5%BD%A6&rft.au=%E6%9C%A8%E7%95%91%2C+%E4%BD%B3%E4%BB%A3%E5%AD%90&rft.date=2010&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%87%A8%E5%BA%8A%E3%83%AA%E3%82%A6%E3%83%9E%E3%83%81%E5%AD%A6%E4%BC%9A&rft.issn=0914-8760&rft.eissn=2189-0595&rft.volume=22&rft.issue=2&rft.spage=236&rft.epage=242&rft_id=info:doi/10.14961%2Fcra.22.236&rft.externalDocID=article_cra_22_2_22_236_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8760&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8760&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8760&client=summon